Heart group warns of cardiovascular risks after treatment for breast cancer
(By Sharon Begley for STAT) Cardiologists are not telling women with breast cancer to decline treatment — far from it. But in
Read More
Part D/Prescription Drugs
As States Target High Drug Prices, Pharma Targets State Lawmakers
(By Jay Hancock and Shefali Luthra for Kaiser Health News) It was expected to be a perfunctory statehouse meeting —
Read MoreMedicare drug wars
The proposed federal policy rule that would make major changes to Medicare Advantage and the Medicare Part D drug program
Read MoreRacing to replace opioids, biopharma is betting on pain drugs with a checkered past
(By Damian Garde for STAT) It was supposed to be a $10 billion idea, one that would help wean the
Read MoreIn State of the Union, Trump endorses ‘right to try’ for terminally ill patients
(By Ike Swetlitz for STAT) WASHINGTON — In a wide-ranging State of the Union address Tuesday evening, President Trump endorsed Congress’s
Read MoreBig Pharma Greets Hundreds Of Ex-Federal Workers At The ‘Revolving Door’
(By Sydney Lupkin for Kaiser Health News) Alex Azar’s job hop from drugmaker Eli Lilly to the Trump administration reflects
Read MoreDid the government overpay for hundreds of drugs? It’s complicated
(By Ike Swetlitz for STAT) WASHINGTON — It looked like the watchdog had found something big — in December 2017,
Read MoreCMS wants to require Medicare Part D sponsors to apply their rebates toward point-of-sales prices
Currently, Medicare Part D plan sponsors use savings they negotiate with drug companies and pharmacies to reduce costs for all
Read MoreCancer Patients Get Little Guidance From Doctors On Using Medical Marijuana
(By Karen Weintraub for NPR) Even three queasy pregnancies didn’t prepare Kate Murphy for the nonstop nausea that often comes
Read MoreHumana faces backlash for hiking breast cancer drug copays
(By Morgan Haefner for Becker’s Hospital Review) Humana recently reclassified Herceptin — an intravenous drug used to treat metastatic breast
Read More